To assess whether GlyRS inhibitors have antiviral effects in the early stages of infection, we treated A549 cells with 10 μM or 20 μM Lycobetaine and Scutellarein for 24 h before PR8 infection and measured viral titer 24 h post-PR8 infection. Here, GARS1 is linked to infection.